The Hepatology & Gastroenterology Unit focuses on the diagnosis and treatment of acute and chronic diseases, and management and care of end-stage liver failure. A multidisciplinary team including transplant and hepatobiliary surgeons, interventional radiologists, endoscopists, pathologists, infectivologists, anesthesiologists and intensive care physicians, nephrologists, cardiologists, and pulmonologists, promotes and coordinates the Unit’s treatment programs.
The Hepatology & Gastroenterology Unit is involved in several national and international clinical studies, and is acknowledged as a center of excellence for advanced treatment of viral hepatitis, hepatitis B and C, hemochromatosis, nonalcoholic steatohepatitis, primary biliary cirrhosis, sclerosing cholangitis, Wilson’s disease, alpha-1-antitrypsin deficiency, hepatocellular carcinoma, cholangiocarcinoma, and other diseases of the liver.
Main inpatient and outpatient clinical activity:
- Selection, assessment, and enrollment on the waiting list of liver transplant candidates.
- Early and late post-op follow-up of liver transplant recipients.
- Selection and clinical management of patients with advanced liver disease complications (portal hypertension, liver neoplasia) eligible for highly-specialized interventional radiology and interventional endoscopy procedures (e.g., TIPS, intra-arterial treatment of hepatocarcinoma, etc.)
Main areas of scientific research include:
- Pre- and post-transplant treatment of HCV and HBV infections.
- Innovative protocols for post-liver transplant immunosuppressive therapy.
- Prognostic models for transplant candidate selection.
- Diagnosis and treatment of portal hypertension and hepatocarcinoma.
- Regenerative medicine and cell transplants.